Technical Analysis for ALLO - Allogene Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.47 | 0.29% | 0.01 |
ALLO closed up 0.29 percent on Friday, April 19, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 1
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.29% | |
| NR7 | Range Contraction | 0.29% | |
| NR7-2 | Range Contraction | 0.29% | |
| Narrow Range Bar | Range Contraction | 0.29% | |
| Lower Bollinger Band Walk | Weakness | 0.29% | |
| Wide Bands | Range Expansion | 0.29% | |
| Oversold Stochastic | Weakness | 0.29% | |
| NR7 | Range Contraction | -1.14% |
| Alert | Time |
|---|---|
| Down 2 % | about 14 hours ago |
| Up 2% | about 19 hours ago |
| Fell Below Previous Day's Low | about 19 hours ago |
| Down 1% | about 19 hours ago |
| Up 1% | about 19 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/01/2024
Allogene Therapeutics is a clinical stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer. Led by a world-class management team with significant experience in cell therapy, we are developing a pipeline of “off-the-shelf” CAR T cell therapy candidates with the goal of delivering readily available cell therapy faster, more reliably and at greater scale to more patients.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Stem Cell Cell Therapy Cell Biology Therapies For Cancer Adoptive Cell Transfer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Stem Cell Cell Therapy Cell Biology Therapies For Cancer Adoptive Cell Transfer
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.89 |
| 52 Week Low | 2.23 |
| Average Volume | 2,237,213 |
| 200-Day Moving Average | 3.79 |
| 50-Day Moving Average | 4.48 |
| 20-Day Moving Average | 3.98 |
| 10-Day Moving Average | 3.74 |
| Average True Range | 0.25 |
| RSI (14) | 30.07 |
| ADX | 23.18 |
| +DI | 13.87 |
| -DI | 29.01 |
| Chandelier Exit (Long, 3 ATRs) | 3.87 |
| Chandelier Exit (Short, 3 ATRs) | 4.14 |
| Upper Bollinger Bands | 4.63 |
| Lower Bollinger Band | 3.33 |
| Percent B (%b) | 0.1 |
| BandWidth | 32.59 |
| MACD Line | -0.27 |
| MACD Signal Line | -0.21 |
| MACD Histogram | -0.0574 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.73 | ||||
| Resistance 3 (R3) | 3.73 | 3.64 | 3.69 | ||
| Resistance 2 (R2) | 3.64 | 3.58 | 3.64 | 3.67 | |
| Resistance 1 (R1) | 3.56 | 3.54 | 3.60 | 3.56 | 3.66 |
| Pivot Point | 3.47 | 3.47 | 3.49 | 3.47 | 3.47 |
| Support 1 (S1) | 3.38 | 3.40 | 3.43 | 3.38 | 3.28 |
| Support 2 (S2) | 3.29 | 3.36 | 3.29 | 3.27 | |
| Support 3 (S3) | 3.21 | 3.29 | 3.25 | ||
| Support 4 (S4) | 3.21 |
